Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Sonoma Pharmaceuticals, Inc. (SNOA)
:SNOA
SNOA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$2.30 - $9.38
Previous CloseN/A
Volume16.09K
Average Volume (3M)46.46K
Market Cap
$3.91M
Enterprise Value-$1.18M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta2.52
Next Earnings
Jul 09, 2025EPS Estimate
-0.73Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-3.93
Shares Outstanding1,615,765
10 Day Avg. Volume25,447
30 Day Avg. Volume46,458
Standard Deviation0.25
R-Squared0.09
Alpha-0.04
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)0.30
Price to Cash Flow (P/CF)1.70
P/FCF Ratio1.70
Enterprise Value/Market Cap-0.30
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit-0.25
Enterprise Value/Ebitda0.29
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
Sonoma Pharmaceuticals News
PremiumCompany Announcements
Sonoma Pharmaceuticals Ends EMC Pharma Agreement
---
Ownership Overview
31.44% Insiders
0.58% Mutual Funds
0.64% Other Institutional Investors
67.33% Public Companies and Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
SNOA FAQ
What was Sonoma Pharmaceuticals, Inc.’s price range in the past 12 months?
Sonoma Pharmaceuticals, Inc. lowest stock price was $2.30 and its highest was $9.38 in the past 12 months.
What is Sonoma Pharmaceuticals, Inc.’s market cap?
Sonoma Pharmaceuticals, Inc.’s market cap is $3.91M.
When is Sonoma Pharmaceuticals, Inc.’s upcoming earnings report date?
Sonoma Pharmaceuticals, Inc.’s upcoming earnings report date is Jul 09, 2025 which is in 137 days.
How were Sonoma Pharmaceuticals, Inc.’s earnings last quarter?
Sonoma Pharmaceuticals, Inc. released its earnings results on Feb 05, 2025. The company reported -$0.594 earnings per share for the quarter, beating the consensus estimate of -$0.69 by $0.096.
Is Sonoma Pharmaceuticals, Inc. overvalued?
According to Wall Street analysts Sonoma Pharmaceuticals, Inc.’s price is currently Overvalued.
Does Sonoma Pharmaceuticals, Inc. pay dividends?
Sonoma Pharmaceuticals, Inc. does not currently pay dividends.
What is Sonoma Pharmaceuticals, Inc.’s EPS estimate?
Sonoma Pharmaceuticals, Inc.’s EPS estimate is -0.73.
How many shares outstanding does Sonoma Pharmaceuticals, Inc. have?
Sonoma Pharmaceuticals, Inc. has 1,615,765 shares outstanding.
What happened to Sonoma Pharmaceuticals, Inc.’s price movement after its last earnings report?
Sonoma Pharmaceuticals, Inc. reported an EPS of -$0.594 in its last earnings report, beating expectations of -$0.69. Following the earnings report the stock price went down -0.376%.
Which hedge fund is a major shareholder of Sonoma Pharmaceuticals, Inc.?
Currently, no hedge funds are holding shares in SNOA
---
Company Description
Sonoma Pharmaceuticals, Inc.
Sonoma Pharmaceuticals, Inc. engages in identifying, developing, and commercializing therapies for chronic skin conditions. The company offers solutions in dermatology, animal healthcare, and advanced tissue care product areas. Its products target skin diseases including acne, atopic dermatitis, scarring, infections, itch, pain, and harmful inflammatory responses. The company was founded by Hojabr Alimi and Linda Alimi in April 1999 and is headquartered in Petaluma, CA.
---
SNOA Stock 12 Month Forecast
Average Price Target
―Technical Analysis
Best Analysts Covering SNOA
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
-60.30%
reiterated a buy rating 8 months ago
Copying Jeffrey Cohen's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of -60.30% per trade.
---